GTC
RVNC
Ghost Tree Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-225,000
| Closed | -$578K | – | 70 |
|
|
2024
Q2 | $578K | Sell |
225,000
-225,000
| -50% | -$578K | 0.18% | 56 |
|
|
2024
Q1 | $2.21M | Buy |
450,000
+75,000
| +20% | +$369K | 0.61% | 47 |
|
|
2023
Q4 | $3.3M | Buy |
375,000
+25,000
| +7% | +$220K | 1.08% | 26 |
|
|
2023
Q3 | $4.01M | Sell |
350,000
-175,000
| -33% | -$2.01M | 1.32% | 21 |
|
|
2023
Q2 | $13.3M | Buy |
525,000
+275,000
| +110% | +$6.96M | 4.39% | 6 |
|
|
2023
Q1 | $8.05M | Sell |
250,000
-50,000
| -17% | -$1.61M | 2.38% | 12 |
|
|
2022
Q4 | $5.54M | Sell |
300,000
-90,000
| -23% | -$1.66M | 2.36% | 18 |
|
|
2022
Q3 | $10.5M | Buy |
+390,000
| New | +$10.5M | 2.96% | 10 |
|
|
2017
Q3 | – | Sell |
-89,295
| Closed | -$2.36M | – | 63 |
|
|
2017
Q2 | $2.36M | Buy |
+89,295
| New | +$2.36M | 0.49% | 49 |
|
|
2015
Q2 | – | Sell |
-200,000
| Closed | -$4.15M | – | 82 |
|
|
2015
Q1 | $4.15M | Buy |
+200,000
| New | +$4.15M | 1.49% | 24 |
|
|
2014
Q3 | – | Sell |
-20,000
| Closed | -$680K | – | 77 |
|
|
2014
Q2 | $680K | Hold |
20,000
| – | – | 0.48% | 42 |
|
|
2014
Q1 | $630K | Buy |
+20,000
| New | +$630K | 0.37% | 46 |
|